Category Archives: Pr Newswire

Aging in Place, Lack of Transportation and Access, and Economic Insecurity Are Top Three Social Barriers to U.S. Senior Health

Alignment Health’s 2024 Social Threats to Aging Well in America survey reveals 1 in 4 seniors skip medical care, 1 in 5 seniors do not have enough money to pay off medical debt in next year ORANGE, Calif. , Aug. 21, 2024 (GLOBE NEWSWIRE) — Alignment Health released its 2024 Social Threats to Aging Well […]

Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

SALT LAKE CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in two upcoming investor healthcare conferences. The Wells Fargo Healthcare Conference in a fireside chat featuring Scott Leffler, Chief Financial Officer, on Sept. 4, 2024 at 1:30pm […]

aTyr Pharma to Participate in September Investor Conferences

SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the company will participate in several upcoming investor conferences scheduled to take place in September 2024. Details of the […]

Waterdrop Inc. to Report Second Quarter 2024 Financial Results on September 4, 2024

BEIJING, Aug. 21, 2024 /PRNewswire/ — Waterdrop Inc. (NYSE: WDH) (“Waterdrop” or the “Company”), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2024, before U.S. markets open on Wednesday, September 4, 2024. Waterdrop’s management team will hold a […]

ESR Group Reports 1H FY2024 Results | Robust strategy execution positions ESR for next phase of growth

Key Highlights: Total Fee-related AUM[1],[2] increased 2.7% year-on-year to US$80 billion US$2.3 billion of new capital raised in 1H FY2024, up 155% on the same period last year ESR positioning for next phase of growth through ongoing balance sheet optimisation, streamlining and simplifying business, and the successful early LOGOS rollup and integration Fully integrated ESR […]

Mega Matrix Announces That the Short Drama “The Billionaire’s Rescue” Will Be Released on August 21 at FlexTV

PALO ALTO, Calif. , Aug. 21, 2024 /PRNewswire/ — Mega Matrix Corp. (“MPU” or the “Company”) (NYSE American: MPU), today announced that it launched its highly anticipated short drama “The Billionaire’s Rescue” on August 21st at FlexTV. In this short drama, we not only witness a touching love story, but also feel the warm moments in […]

NTT Drives Hong Kong Smart City Innovation With Private 5G For New Use Cases

With Hong Kong’s First Localized Wireless Broadband System (Private) License, the newly launched docomo 5G DX Square provides innovators a stable and scalable wireless backbone for future smart city POCs. HONG KONG, Aug. 21, 2024 /PRNewswire/ — NTT Com Asia (NTT) is giving smart city development in Hong Kong a significant boost by establishing a […]

Incorporating AI into Your Small Business Marketing Strategy with ideas from GoDaddy

ISLAMABAD, Aug. 21, 2024 /PRNewswire/ — In today’s fast-paced digital world, one of the ways small businesses can stay competitive is by adopting innovative marketing strategies. Incorporating new technologies into marketing strategies can help to save time and drive engagement with current and potential customers. Artificial intelligence (AI) is revolutionizing the marketing landscape, making it […]

Regeneron Provides Update on Biologics License Application for Linvoseltamab

TARRYTOWN, N.Y., Aug. 20, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for linvoseltamab in relapsed/refractory (R/R) multiple myeloma (MM) that has progressed after at least three prior therapies. This anticipated […]

Eyenovia, Inc. Announces Proposed Public Offering

NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today that it intends to offer and sell shares of its common stock (or pre-funded warrants in lieu thereof) in a best efforts offering. All of the securities to be sold in the offering […]